In summary, the current study provided evidence that miR‐34a contained in BM‐MSC‐derived Evs could bind to the 3' UTR of cyclin I and further enhance the activation of the ATM/ATR/p53 signalling pathway, thus promoting RA‐FLS apoptosis and reducing RA inflammation. Here, CCNI is linked to rheumatoid arthritis.